CVS vs RYTM · P/E 16, rev $402.07B vs rev $130.1M
CVS Health Corp (CVS) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the CVS and RYTM stock pages for the full models.
Not investment advice.